Spectrum of cancer risk among US solid organ transplant recipients, JAMA, vol.306, p.1891, 2011. ,
Cancer incidence before and after kidney transplantation, JAMA, vol.296, p.2823, 2006. ,
Epidemiology of posttransplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: report of the French registry and analysis of subgroups of lymphomas: PTLD French Registry, Am J Transplant, vol.12, p.682, 2012. ,
Epstein-Barr virus infection and posttransplant lymphoproliferative disorder: EBV and PTLD, Am J Transplant, vol.13, p.41, 2013. ,
DOI : 10.1111/ajt.12004
Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non-Hodgkin lymphoma, Transplantation, vol.88, p.962, 2009. ,
Post-transplant lymphoproliferative disorders, Nat Rev Dis Primer, vol.2, p.15088, 2016. ,
Antiviral prophylaxis and the Epstein Barr virusrelated post-transplant lymphoproliferative disorder, Clin Transplant, vol.9, p.53, 1995. ,
DOI : 10.1007/bf00838054
Reduced incidence of EpsteinBarr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy, Transplantation, vol.64, p.848, 1997. ,
Prevention and preemptive therapy of posttransplant lymphoproliferative disease in pediatric liver recipients, Transplantation, vol.66, p.1604, 1998. ,
Antiviral prophylaxis reduces the incidence of lymphoproliferative disease in lung transplant recipients, J Heart Lung Transplant, vol.21, p.547, 2002. ,
Ganciclovir and acyclovir reduce the risk of posttransplant lymphoproliferative disorder in renal transplant recipients: anti-virals reduce risk of PTLD, Am J Transplant, vol.5, p.2894, 2005. ,
Effect of cytomegalovirus prophylaxis with immunoglobulin or with antiviral drugs on post-transplant nonHodgkin lymphoma: a multicentre retrospective analysis, Lancet Oncol, vol.8, p.212, 2007. ,
Expression and localization of the Epstein-Barr virus-encoded protein kinase, J Virol, vol.78, p.12140, 2004. ,
Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation, N Engl J Med, vol.306, p.913, 1982. ,
Cellular normalization of viral DNA loads on whole blood improves the clinical management of cytomegalovirus or Epstein Barr virus infections in the setting of pre-emptive therapy, J Med Virol, vol.81, p.90, 2009. ,
Epidemiology and morbidity of Epstein-Barr virus infection in pediatric renal transplant recipients: a multicenter, prospective study, Clin Infect Dis, vol.56, p.84, 2013. ,
Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study, Transpl Infect Dis, vol.18, p.423, 2016. ,
Human B-cell lymphoma in severe combined immunodeficient mice after active infection with Epstein-Barr virus, Surgery, vol.112, p.378, 1992. ,
The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and posttransplant lymphoproliferative disease following solid organ transplantation, Transpl Infect Dis, vol.3, p.97, 2001. ,
Val-)Ganciclovir prophylaxis reduces Epstein-Barr virus primary infection in pediatric renal transplantation: (Val-) Ganciclovir reduces EBV primary infection, Transpl Int, vol.25, p.723, 2012. ,
Monitoring infection with Epstein-Barr virus among seromismatch adult renal transplant recipients: preventing PTLD in EBV mismatch transplants, Am J Transplant, vol.11, p.1058, 2011. ,
The role of antiviral prophylaxis for the prevention of Epstein-Barr virusassociated posttransplant lymphoproliferative disease in solid organ transplant recipients: a systematic review, Am J Transplant, vol.17, p.770, 2017. ,
Risk factors for posttransplant lymphoproliferative disorder in pediatric liver transplant recipients with cytomegalovirus antigenemia, Transplant Proc, vol.42, p.895, 2010. ,
Response of elevated Epstein-Barr virus DNA levels to therapeutic changes in pediatric liver transplant patients: 56-month follow up and outcome, Transplantation, vol.74, p.367, 2002. ,
Prospective longitudinal analysis of quantitative Epstein-Barr virus polymerase chain reaction in pediatric liver transplant recipients, Transplantation, vol.67, p.1068, 1999. ,
The role of valacyclovir on Epstein-Barr virus viral loads in pediatric liver transplantation patients, Transplant Proc, vol.41, p.2878, 2009. ,
Epstein-Barr virus primary mismatching and HLA matching: key risk factors for post lung transplant lymphoproliferative disease, Transplantation, vol.78, p.205, 2004. ,
Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients, J Heart Lung Transplant, vol.17, p.1161, 1998. ,
Associations between EBV serostatus and organ transplant type in PTLD risk: an analysis of the SRTR National Registry Data in the United States, Am J Transplant, vol.12, p.976, 2012. ,
Persistence of the Epstein-Barr virus and the origins of associated lymphomas, N Engl J Med, vol.350, p.1328, 2004. ,
Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model, J Virol, vol.79, p.13993, 2005. ,
A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas, J Virol, vol.85, p.165, 2011. ,
Knockout of Epstein-Barr virus BPLF1 retards B-cell transformation and lymphoma formation in humanized mice, MBio, vol.6, p.1574, 2015. ,
In vivo intratumoral Epstein-Barr virus replication is associated with XBP1 activation and early-onset posttransplant lymphoproliferative disorders with prognostic implications, Mod Pathol, vol.27, p.1599, 2014. ,
Pretransplantation assessment of the risk of lymphoproliferative disorder, Clin Infect Dis, vol.20, p.1346, 1995. ,
Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease, J Infect Dis, vol.176, p.1462, 1997. ,
Importance of events per independent variable in proportional hazards analysis I. Background, goals, and general strategy, J Clin Epidemiol, vol.48, p.1495, 1995. ,
Relaxing the rule of ten events per variable in logistic and Cox regression, Am J Epidemiol, vol.165, p.710, 2007. ,